Grown Rogue International Inc. Share Price OTC Markets
Stocks
GRUS.F
CA39986R3045
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4483 USD | -3.59% |
|
+3.25% | -13.10% |
| 05-12 | Grown Rogue International Inc., Q1 2026 Earnings Call, May 12, 2026 | |
| 05-12 | Grown Rogue International Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 112M 97.11M 89.49M 83.77M 157M 10.69B 159M 1.06B 412M 5.2B 422M 413M 18.01B | P/E Ratio 2024 |
-12x | P/E Ratio 2025 | 71.9x |
|---|---|---|---|---|---|
| Enterprise Value | 128M 110M 102M 95.16M 178M 12.14B 181M 1.2B 468M 5.91B 479M 469M 20.46B | EV / Sales 2024 |
5.45x | EV / Sales 2025 | 4.4x |
| Free-Float |
61.83% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Grown Rogue International Inc.
| 1 day | -3.59% | ||
| 1 week | +3.25% | ||
| Current month | +9.34% | ||
| 1 month | +24.53% | ||
| 3 months | +40.09% | ||
| 6 months | +16.44% | ||
| Current year | -13.10% |
| 1 week | 0.42 |  | 0.49 |
| 1 month | 0.33 | | 0.49 |
| Current year | 0.27 | | 0.52 |
| 1 year | 0.27 | | 0.52 |
| 3 years | 0.12 | | 0.9 |
| 5 years | 0.02 | | 0.9 |
| 10 years | 0 | | 0.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Strickler
CEO | Chief Executive Officer | 45 | 14/11/2018 |
Sarah Strickler
PRN | Corporate Officer/Principal | - | 30/09/2016 |
| Director of Finance/CFO | 42 | 31/12/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Gledhill
BRD | Director/Board Member | 64 | 14/11/2018 |
J. Strickler
BRD | Director/Board Member | 45 | 14/11/2018 |
Ryan Kee
BRD | Director/Board Member | 42 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.59% | +3.25% | - | - | 112M | |
| +0.10% | +4.12% | -11.21% | -3.71% | 13.31B | |
| +2.67% | +0.40% | -33.64% | -55.67% | 4.92B | |
| +0.90% | +3.87% | -8.38% | -1.94% | 4.74B | |
| +2.11% | -3.36% | +10.66% | -20.14% | 3.78B | |
| +3.15% | +3.56% | +5.93% | -41.49% | 3.76B | |
| +2.81% | -1.45% | -2.55% | -8.26% | 3.59B | |
| +1.48% | +2.49% | -12.35% | -4.51% | 3.13B | |
| +5.11% | +2.56% | -9.19% | -28.61% | 2.25B | |
| +0.87% | -2.57% | -14.39% | +25.48% | 1.72B | |
| Average | +1.56% | +1.23% | -8.35% | -15.43% | 4.58B | |
| Weighted average by Cap. | +1.59% | +1.67% | -9.35% | -15.26% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 27.02M 23.33M 21.5M 20.13M 37.72M 2.57B 38.31M 254M 98.99M 1.25B 101M 99.24M 4.33B | 32.43M 28.01M 25.81M 24.16M 45.28M 3.08B 45.98M 305M 119M 1.5B 122M 119M 5.19B |
| Net income | -11.3M -9.76M -9M -8.42M -15.78M -1.07B -16.03M -106M -41.42M -523M -42.42M -41.52M -1.81B | 1.73M 1.49M 1.38M 1.29M 2.42M 164M 2.45M 16.26M 6.34M 80.03M 6.49M 6.35M 277M |
| Net Debt | 3.7M 3.2M 2.95M 2.76M 5.17M 352M 5.25M 34.81M 13.57M 171M 13.9M 13.61M 593M | 15.3M 13.21M 12.18M 11.4M 21.36M 1.45B 21.69M 144M 56.06M 708M 57.42M 56.2M 2.45B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/06/26 | 0.4483 $ | -3.59% | 67,786 |
| 11/06/26 | 0.4650 $ | +4.75% | 79,180 |
| 10/06/26 | 0.4439 $ | -4.25% | 37,565 |
| 09/06/26 | 0.4636 $ | -3.42% | 257,534 |
| 08/06/26 | 0.4800 $ | +10.55% | 574,711 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GRIN Stock
- GRUS.F Stock
Select your edition
All financial news and data tailored to specific country editions
